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A B S T R A C T   
Background: We investigated the feasibility, acceptability, safety, and preliminary effectiveness of the Counsel-
ling for Alcohol Problems (CAP) psychological intervention delivered by non-specialist health workers (NSHW) 
to participants with alcohol use disorder (AUD) and comorbid depression in primary care. 
Methods: We used data from a single blind randomised controlled trial conducted in ten primary health care 
centres in Goa, India. Adult male harmful or dependent drinkers with or without depression were randomized 
(1:1) to receive either CAP & enhanced usual care (EUC) or EUC only. Process indicators such as the number of 
completed counselling sessions were assessed and compared between comorbid and non-comorbid participants. 
Remission from AUD and depression along with abstinence were measured at 3 and 12 months post random-
isation. Analyses were on an intention-to-treat basis, employing multivariable regression analyses. 
Results: 271 participants had symptoms of comorbid depression; 241 did not. Both groups completed a similar 
number of counselling sessions (adjusted Mean Difference 0.05, 95 %CI − 0.24–0.34;p = 0.72). Among comorbid 
participants, CAP did not lead to more frequent adverse events compared to EUC only (adjusted Odds Ratio 
[aOR] 0.84, 0.43–1.64;p = 0.62), and there was no evidence for an effect of CAP on remission from AUD or 
depression at 3 months (aOR 1.51, 0.84–2.74;p = 0.17 and aOR 0.74, 0.43–1.27;p = 0.28) and 12 months follow- 
up, respectively (aOR 1.69, 0.96–3.01;p = 0.08 and aOR 1.08, 0.62–1.87;p = 0.79). 
Conclusions: Brief therapies like CAP can be safely delivered by NSHWs to patients with comorbid AUD and 
depression, but their effectiveness may be limited and requires further investigation.   
1. Introduction 
Alcohol Use Disorder (AUD) and depression account for a substantial 
burden of disease worldwide (Patel et al., 2016), and have a significant 
impact on a person’s quality of life, resulting in a reduced ability to 
participate in social as well as occupational life. In India, depression and 
AUD are both relatively common in men: in the 2016 National Mental 
Health Survey (NMHS), the prevalence of depression and AUD was 
estimated to be 2.4 % and 9.1 % respectively (Gururaj et al., 2016). The 
experience of these disorders appears to be linked - comorbid depression 
and AUD was recently found to be the most common dual mental 
comorbidity in India (Gururaj et al., 2016), and there is evidence from 
high-income settings suggesting that the presence of either AUD or 
depression significantly increases the risk of the other disorder (Boden 
and Fergusson, 2011; Crum et al., 2008; Fergusson et al., 2009). The 
treatment needs for this group are especially high because the negative 
impact of these comorbid disorders greatly exceeds the effect of a single 
disorder (Carton et al., 2018; Saatcioglu et al., 2008). This comorbidity 
results in substantial costs to society due to high health-care utilisation, 
sub-optimal treatment outcomes, and lost productivity (Chisholm et al., 
2003; Rehm et al., 2009). 
There is accumulating evidence that integrated psychological 
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interventions can effectively treat both AUD and depression for people 
with comorbidity (Baker et al., 2012). However, some psychopatho-
logical symptoms comorbid with AUD are potentially due to the direct 
psychotropic effect of alcohol, and comorbid depressive symptoms 
significantly subside following a 4 to 5-week period of abstinence 
(Liappas et al., 2002). Hence, it is plausible that delivering 
evidence-based interventions only targeting AUD to patients with co-
morbid depression may have a beneficial effect in accelerating 
improvement of depression symptoms. The existing evidence for this is 
mixed, with psychological interventions targeting alcohol use in co-
morbid AUD and depression leading to improved drinking outcomes but 
no effect on the symptoms of depression in some studies (Satre et al., 
2016) and not having any effect even on the drinking outcomes in others 
(Grothues et al., 2008). On this background of inconclusive and con-
flicting evidence it is difficult to make a definitive recommendation. 
Thus, guidelines such as those by the International Society of Addictions 
Medicine, and others suggest treating the substance use disorder first 
and to initiate treatment for depression only if it persists after a period of 
abstinence or reduced drinking (Hassan, 2017; El-Guebaly et al., 2020). 
Access to evidence-based care remains limited due to systemic bar-
riers such as availability, affordability, provider skills and knowledge 
(Saunders et al., 2006). Hence the treatment gap for AUD and depression 
in India is estimated to be more than 85 % for each disorder (Gururaj 
et al., 2016). One way to overcome health system barriers, especially in 
resource-poor settings, is to deliver interventions through task sharing 
(i.e. rational redistribution of tasks among health workforce teams) 
using non-specialist health workers (NSHW) to address the shortage of 
specialist human resources. 
There is growing evidence supporting the effectiveness of NSHW- 
delivered interventions for AUDs as well as depression in low- and 
middle-incomce countries (LMICs) (van Ginneken et al., 2013). 
Furthermore, there is modest evidence supporting counselling for AUD 
in primary care settings (Jonas et al., 2012). There is clear evidence 
which shows that specific, well defined psychosocial therapies such as 
brief counselling, motivational enhancement therapy, community rein-
forcement approach, guided self-change, behaviour contracting, and 
social skills training are effective interventions for AUDs, together with 
some pharmacological interventions (Carvalho et al., 2019). 
Thus, although there is good evidence for psychosocial treatments 
for AUD and modest and emerging evidence of effective NSHW deliv-
ered interventions for AUD in primary care, there is a lack of evidence on 
whether such interventions for AUD delivered by NSHWs would be 
effective in patients with comorbid AUD and depression; and to the best 
of our knowledge, this has not been tested in low-resource settings. The 
aim of this paper is to address this using data from the PREMIUM 
(Program for Effective Mental Health Interventions in Under-Resourced 
Health Systems) randomized controlled trial (RCT) conducted in Goa, 
India (Patel et al., 2014), in which the Counselling for Alcohol Problems 
(CAP) intervention was tested in harmful and dependent drinkers 
(Nadkarni et al., 2019, 2017, 2015). In this paper, we analyse data from 
the CAP trial to investigate a) the feasibility of identifying and recruiting 
men with probable AUD and comorbid depression in primary care, b) 
the feasibility of delivering a brief treatment for such patients by lay 
counsellors in primary care, c) the acceptability and safety of the 
treatment, and d) preliminary evidence of impact of the treatment on 
drinking and depression. We compare the data of comorbid participants 
in the CAP trial with the data of those with AUD without comorbid 
depression to explore whether the effect of the CAP intervention is 
modified by the presence of comorbidity. 
2. Methods 
2.1. Registration and ethical approval 
A detailed description of the PREMIUM trial can be found in the 
study protocol (ISRCTN76465238) and in previous publications (Nad-
karni et al., 2017; Patel et al., 2017, 2014). The study was approved by 
the Institutional Review Boards of the London School of Hygiene and 
Tropical Medicine, the Indian Council of Medical Research and Sangath. 
2.2. Study setting 
The trial was conducted in Goa, a small state in Western India. Goa is 
among the more developed states of India, and alcohol is available at 
comparatively cheap rates. The prevalence of AUD and common mental 
disorders in primary care in Goa has been reported as 8.2 % and 18.8 % 
respectively (D’Costa et al., 2006; Patel et al., 1998). 
2.3. Study design and participants 
The PREMIUM trial was implemented as a parallel-arm, single blind 
individually randomised controlled trial in 10 primary health centres 
(PHCs) across Goa. It was originally designed to test the effectiveness of 
two brief treatments – one (CAP) for patients with AUD, and a second 
one (the Healthy Activity Program (HAP)) for patients with depression – 
in two different trials (referred to as the CAP trial (Nadkarni et al., 2017) 
and the HAP trial (Patel et al., 2017) in the following). For the current 
study, only data of patients in the CAP trial were analysed. 
For the CAP trial, patients at PHCs were eligible for screening if they 
identified as male, since the prevalence of AUD in women is very low in 
India (Gururaj et al., 2016). Additionally, patients needed to be 18–65 
years old, reside in the respective PHC’s catchment area and plan to do 
so for the following year, be able to to communicate clearly, and un-
derstand one of the four languages the intervention was offered in. Pa-
tients presenting with medical emergencies were excluded. Screening 
for AUD was conducted using the AUDIT (Alcohol Use Disorders Iden-
tification Test) screening tool, a WHO-developed screening question-
naire which comprises of 10 items and has been validated for use in 
India (Pal et al., 2004). For the outcome evaluation the AUDIT questions 
were adapted to cover a period of three months as has been done by 
other researchers (Kunz et al., 2004). The 9-item PHQ-9 (Patient Health 
Questionnaire-9) was used to screen for probable depression (Patel 
et al., 2008). 
Patients were invited to take part in the CAP trial if they were 
screened to be either harmful or dependent drinkers (AUDIT score ≥12 
(Saunders et al., 1993)) – regardless of their score on the PHQ-9). 
Written or verbal informed consent was obtained from all participants; 
verbal consent was witnessed and formally recorded. In the context of 
this paper, data of all participants who agreed to take part in the CAP 
trial are analysed. Among those, participants were classified as comor-
bid if they exhibited at least mild symptoms of depression (PHQ-9 ≥5) in 
addition to their harmful or dependent drinking; otherwise, they were 
not. 
A randomisation list stratified by PHC, created by an independent 
statistician, served as basis for random allocation of patients to either 
CAP plus Enhanced Usual Care (EUC) or EUC only. Using sequentially 
numbered opaque sealed envelopes, participants were randomized to 
one of the trial arms individually after baseline assessments had been 
completed. The screening, enrolment, consenting, baseline assessments 
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and assignment of participants to trial arms based on the allocation 
sequence was done by trained and supervised field workers. 
Participants were enrolled in the trial until the sample size specified 
in the PREMIUM study protocol (Patel et al., 2014) was reached. This 
sample size was powered to test the effectiveness of the CAP interven-
tion in probable harmful drinkers (AUDIT score of 12–19) as described 
in an earlier publication (Nadkarni et al., 2017). The trial was not 
powered to estimate the effectiveness of the intervention for comorbid 
patients. 
Screening started on Oct 28, 2013 and was completed on July 29, 
2015. Outcome assessment took place both at 3- and 12-months post- 
randomisation with the last assessment taking place on Aug 30, 2016. 
The outcome assessors and lead investigators were blinded to the allo-
cation status. 
2.4. Intervention 
Enhanced usual care (EUC) included provision of the WHO Mental 
Health GAP Action Programme (mhGAP) guidelines for management of 
AUD to the physician which also included recommendations on man-
agement of alcohol dependence in primary care and referral to specialist 
care as needed. In addition, the AUDIT screening results were provided 
to individual patients. Participants allocated to CAP received both CAP 
and EUC. CAP is a manualised psychological treatment informed by 
motivational interviewing and is delivered over a maximum of four 
sessions, though the optimal number is two. Sessions took place at 
weekly to fortnightly intervals and lasted 30− 45 min. CAP consists of 
three phases: detailed assessment followed by personalised feedback in 
the initial phase; cognitive and behavioural skills and techniques, con-
sisting of drink refusal skills, handling of peer pressure, problem-solving 
skills, and handling of difficult emotions in the middle phase; and 
learning how to manage potential or actual relapses in the ending phase. 
Additionally, those with alcohol dependence were given detailed in-
formation about and offered referral to local de-addiction centres where 
they could access services for medically assisted detoxification. 
The CAP intervention was provided by 11 trained lay health workers 
(LHWs) with no previous background in mental health. All LHWs had at 
least completed high school education and were fluent in the vernacular 
languages used by study participants. Throughout the course of the trial, 
they underwent weekly supervision to ensure optimal delivery of the 
CAP treatment. A more detailed report of counsellor selection as well as 
training and supervision can be found in previous publications (Singla 
et al., 2014). A detailed description of the intervention and training 
material can be viewed online (https://nextgenu.org/course/view.php? 
id=229 and https://www.sangath.in/wp-content/uploads/2018/03/Co 
unselling-for-Alcohol-Problems_Manual.pdf). 
2.5. Measures 
2.5.1. Baseline measures 
At baseline, basic sociodemographic parameters along with AUDIT 
and PHQ-9 scores were assessed. Additionally, readiness to change was 
measured using a five-point Likert scale (ranging from 1=” not useful at 
all” to 5=”very useful” and 1=”not at all” to 5=”already trying to 
change”, respectively). 
2.5.2. Acceptability and feasibility indicators 
Over the course of the intervention, data were collected on accept-
ability and safety. These included the number of completed counselling 
sessions, session duration, homework completion, involvement of Sig-
nificant Other (SO) in sessions and Serious Adverse Events (SAEs). A SAE 
was defined as either death due to any cause, unplanned hospitalization 
or suicidal behaviour. A patient was classified as a planned discharge if 
any of treatment completion was decided in consensus with the coun-
sellor, drinking goals were achieved, or all four counselling sessions 
were completed. 
2.5.3. Clinical outcomes 
A full overview of outcomes assessed in the PREMIUM trial can be 
found in the study protocol (Patel et al., 2014). The following outcomes 
were assessed 3 and 12 months after randomisation: Remission from 
depression (defined as PHQ-9 score < 5), AUD remission (defined as 
AUDIT score < 8) and abstinence. Abstinence was determined through 
the Time Line Follow Back (TLFB) tool, which has been shown to reduce 
bias in retrospectively assessing alcohol consumption over a specified 
timeframe (Sobell and Sobell, 1992). Abstinence was defined as not 
having consumed any alcohol over the 14 days prior to assessment. 
2.6. Statistical analysis 
We calculated frequencies and proportions for categorical variables 
and means and standard deviations for continuous variables at baseline. 
For the analysis of process indicators, we employed descriptive sta-
tistics to present treatment acceptability and feasibility measures for 
comorbid and non-comorbid trial participants respectively. To test for 
differences between these two groups with regard to the process in-
dicators, we conducted multivariable regression analyses adjusting for 
PHCs as a fixed effect. 
Analysis of outcome data was conducted on an intention-to-treat 
basis with multiple imputation for missing outcome data using classifi-
cation and regression trees. This was done because we assumed missing 
data to be missing not completely at random. We then used multivari-
able logistic regression to calculate adjusted Odds Ratios (aORs). In all 
regression models, we adjusted for PHCs as a fixed effect to allow for 
between-clinic clustering. For regression analyses using data of comor-
bid participants only, we additionally adjusted for education and marital 
status, which appeared imbalanced between the trial arms at baseline. 
We used likelihood ratio tests to assess statistical significance. All 
analysis was done using RStudio version 3.6.0. 
3. Results 
3.1. Recruitment and screening process Figure 1  
For the original PREMIUM trial, 73,887 patients were assessed for 
eligibility at ten PHCs, of whom 14,773 (20.0 %) were eligible and were 
screened for AUD and depression. Of these, 885 (6.0 %) participants 
screened positive for AUD (AUD≥12) overall, and 421 (2.8 %) also had 
at least mild symptoms of comorbid depression. 512 patients (57.9 %) 
agreed to take part in the CAP trial, with 257 (50.2 %) randomized to 
CAP + EUC and 255 (49.8 %) randomized to EUC only. Of the 512 CAP 
trial participants, 271 (52.9 %) were classified as comorbid with 
depression. Of these, 136 (50.2 %) were in the CAP + EUC trial arm, and 
135 (49.8 %) were in the EUC-only arm. Of the 231 trial participants 
with AUD only, 121 (50.2 %) were in the CAP + EUC arm and 120 (49.8 
%) were in the EUC-only arm. 
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3.2. Baseline measures 
A summary of baseline measures for participants enrolled in the CAP 
trial is presented in Table 1. 
Within the group of comorbid patients, those randomized to CAP +
EUC were less likely to be married and more likely to have completed at 
least secondary education, while other parameters were found to be 
comparable between the two groups. Within the group of participants 
with AUD only, all measured parameters were evenly distributed 
(Table 1). Comparing all comorbid patients to the group of all patients 
with AUD only, mean AUDIT score was higher in the comorbid group 
compared to those with only AUD (18.75, SD = 5.3 versus 15.78, SD =
3.9, p < 0.001), and a greater readiness to change was observed (87.1 % 
Fig. 1. Flowchart of the Counselling for Alcohol Problems trial.  
Table 1 
Baseline characteristics of comorbid participants and participants with AUD 
only.  
Measure 
Comorbid (n = 271) AUD only (n = 241) 
CAP + EUC 
(n = 136) 
EUC only 
(n = 135) 
CAP + EUC 
(n = 121) 
EUC only 
(n = 120) 








Marital status (n, %) 
Married 101 (74.3) 112 (83.0) 97 (80.2) 96 (80.0) 
Occupation (n, %) 
Unemployed 23 (16.9) 20 (14.8) 14 (11.6) 18 (15.0) 
Education (n, %) 
Completed secondary 
education or higher 
41 (30.1) 30 (22.2) 34 (28.1) 38 (31.7) 
Patient’s expectation of usefulness of counselling (n, %) 
A little/somewhat 
useful 
23 (16.9) 29 (21.5) 24 (19.8) 25 (20.8) 
Moderately useful to 
very useful 
113 (83.1) 106 (78.5) 97 (80.2) 95 (79.2) 
Mean AUDIT score (SD) 18.60 (5.3) 18.89 (5.4) 15.61 (3.6) 15.96 (4.2) 
Mean PHQ-9 score (SD) 9.92 (4.5) 10.42 (4.4) 1.82 (1.4) 1.77 (1.44) 
Readiness to change (n, %) 
Not at all/ little/ 
somewhat trying 
22 (15.6) 13 (10.3) 23 (18.3) 24 (20.7) 
Ready to already 
trying 
114 (84.4) 122 (89.7) 98 (81.7) 96 (79.3) 
Notes. AUDIT = Alcohol Use Disorder Identification Test, PHQ-9 = Patient 
Health Questionnaire-9. 
Table 2 
Comparison between acceptability and feasibility indicators between comorbid 
patients and patients with AUD only.  
Measure Comorbid (n 
= 136) 
AUD only 
(n = 121) 
Effect measure 
(95 % CI) 
p 
Mean number of 
sessions (SD) 
2.36 (1.2) 2.32 (1.1) 0.05c (− 0.24 – 
0.34) 
0.72 
Mean duration of 
sessions in minutes 
(SD) 





73 (76.5)a 68 (80.0)a 0.88d 
(0.40–1.92) 
0.75 
Planned discharge (n, 
%) 
86 (63.2) 85 (70.2) 0.72d 
(0.41–1.24) 
0.24 
SO involvementb (n,%)     
Session 2 17 (18.5)b 13 (15.3)b 1.78d 
(0.75–4.41) 
0.20 
Session 3 8 (12.5)b 4 (7.7)b 2.09d 
(0.57–9.14) 
0.29 
Session 4 0 (0) 0 (0) NA NA 
Notes: SO = Significant Other, a = among those assigned homework, b = among 
those attending the respective session, c = adjusted mean difference, d =
adjusted odds ratio. All regression analyses controlling for PHC as fixed effect. 
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of comorbid patients ready or already trying to change versus 80.4 % of 
non-comorbid patients, p = 0.06). 
3.3. Acceptability, feasibility and safety 
Within the group of comorbid patients, 128 (94.1 %) completed the 
first session of CAP, 96 (70.6 %) completed the second session, 65 (47.8 
%) the third session and 28 (20.6 %) the fourth session, respectively. 
These proportions are comparable to those in the group with AUD only 
(93.4 %; 72.7 %; 46.3 %; 17.4 % respectively). 
Key indicators describing the acceptability and feasibility of the CAP 
treatment for both comorbid and non-comorbid patients are displayed in 
the following (Table 2). 
Comparing values for the comorbid cohort to those obtained for the 
group with AUD only suggests no evidence of differential acceptability 
and feasibility (Table 2). 
Analysis of safety indicators showed that in the group of comorbid 
patients, the number of patients with at least one SAE was higher (n =
41, 15.1 % vs. n = 23, 9.5 %, aOR = 3.66, 95 % CI 1.38–11.56, p = 0.01). 
Among comorbid patients, those who received CAP + EUC treatment 
had a similar number of patients with at least one SAE as the group 
which received only EUC (n = 22, 16.2 % vs. n = 19, 14.0 %, aOR =
0.84, 95 % CI 0.43–1.64, p = 0.62). 
3.4. Preliminary analysis of effectiveness 
Follow-up rates were high at both 3 months and 12 months. Of the 
comorbid patients, 242 (89.3 %) completed a 3 month outcome 
assessment and 228 (84.8 %) completed the 12 month assessment. The 
proportions were similar in the AUD-only participants (89.2 % and 84.8 
% respectively). Of the baseline measures, only age proved a significant 
predictor of drop-out: patients below 40 years were less likely to drop 
out after 3 months and 12 months respectively (OR = 0.41, 95 % CI 
0.23–0.73; OR = 0.53, 95 % CI 0.32–0.85). 
Among the comorbid participants, there was no evidence of a dif-
ference between the two arms for the two AUD-related outcomes at any 
time point, though the proportion of participants with AUD remission 
and of non-drinkers was consistently higher among those who received 
CAP + EUC vs EUC-only (Table 3). There was no evidence of an inter-
vention effect on remission from depression. 
Among patients with AUD only, there was strong evidence of an 
intervention effect on AUD remission and non-drinking at both 3 months 
and 12 months (Table 3). Additionally, there was strong evidence sug-
gesting that the effect of CAP on abstinence at 3 months follow-up was 
modified by the presence of comorbidity (aOR of interaction term 3.23, 
95 % CI 1.34–7.79, p < 0.01), whereas for all other outcomes, this was 
not the case. 
4. Discussion 
Our results suggest that identifying patients with comorbid AUD and 
depression in a primary care setting is feasible, and that the acceptability 
and safety of the CAP treatment among these patients is generally 
satisfactory and comparable to a group of patients with AUD without 
symptoms of comorbid depression. Exploratory findings from the group 
of comorbid patients suggest that although delivering CAP does not 
seem to result in more frequent remission from depression compared to 
EUC only, it may have a positive effect on AUD-related outcomes. 
Among participants with AUD only, there was strong evidence for a 
positive effect of CAP on both remission from AUD and abstinence. 
This study makes an important contribution to the existing literature 
since, to the best of our knowledge, it is the first to test such a treatment 
for patients with comorbid depression and AUD in a LMIC-setting. Our 
findings add to the evidence supporting the feasibility of a task-sharing 
approach in countries where insufficient resources hamper the provision 
of essential treatment for mental disorders (Chibanda et al., 2015; 
Nadkarni et al., 2017; Patel et al., 2017). In this study, even in the case of 
comorbid patients with potentially complex clinical pictures, NSHWs 
were able to deliver a brief treatment safely while overall maintaining 
satisfying engagement comparable to non-comorbid participants in the 
trial. In particular, drop-out was low in this study, which may be partly 
explained by direct recruitment of participants at PHCs and the delivery 
of CAP by NSHWs in vernacular languages. 
Among the comorbid patients, the proportion classified as abstinent 
or remitted from AUD was found to be higher in the group of patients 
who received CAP + EUC compared to only EUC at both 3 months and 
12 months follow-up. This trial was not powered to demonstrate the 
effectiveness of CAP in a comorbid sample, but provides an indication of 
a positive effect of CAP + EUC in comorbid patients to be investigated in 
future studies. The effectiveness of CAP appears higher among patients 
with AUD only, for both AUD-related outcomes, and at both 3 and 12 
months follow-up; however, strong evidence for a modification of the 
effect of CAP by the presence of comorbidity was only found for absti-
nence at 3 months follow-up. 
Table 3 
Outcome data for comorbid and non-comorbid CAP participants per trial arm at 3 and 12 months follow-up.   
Comorbid AUD only 








aOR (95 % CI) p 
AUD remission (AUDIT < 8) (n,%) 37 (31.4) 29 (23.4) 1.51 
(0.84–2.74) 
0.17 38 (36.2) 24 (21.8) 1.84 
(1.00–3.41) 
0.05 
Non-drinker (n,%) 47 (39.8) 38 (30.6) 1.48 
(0.86–2.55) 
0.16 42 (40.0) 12 (10.9) 4.64 
(2.32–9.28) 
<0.01 
PHQ-9 remission (PHQ-9 < 5) (n, 
%) 
51 (43.2) 61 (49.2) 0.74 
(0.43–1.27) 
0.28 NA NA NA NA  




aOR (95 % CI) p CAP + EUC (n = 99) EUC (n =
102) 
aOR (95 % CI) P 
AUD remission (AUDIT < 8) (n,%) 48 (42.9) 30 (26.1) 1.69 
(0.96–3.01) 
0.08 53 (53.5) 32 (31.4) 2.47 
(1.34–4.57) 
<0.01 
Non-drinker (n,%) 47 (42.0) 35 (30.4) 1.39 
(0.76–2.50) 
0.28 42 (42.4) 24 (23.5) 2.17 
(1.18–3.98) 
0.01 
PHQ-9 remission (PHQ-9 < 5) (n, 
%) 
62 (55.4) 56 (48.7) 1.08 
(0.62–1.87) 
0.79 NA NA NA NA 
Notes. CAP = Counselling for Alcohol Problems, EUC = Enhanced Usual Care. AUDIT = Alcohol Use Disorder Identification Test, PHQ-9 = Patient Health 
Questionnaire-9, aOR = adjusted Odds Ratio. All aORs adjusted for Primary Healthcare Centre; aORs in comorbid group additionally adjusted for marital status and 
education. Missing outcome values for all variables were imputed via multiple imputation using classification and regression trees. 
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Interestingly, this effect measure modification is mostly explained by 
a differential response to EUC only rather than to CAP + EUC. While 
among participants who received CAP + EUC, a similar proportion of 
patients was classified as abstinent in the comorbid and non-comorbid 
group at 3 months follow-up, a lower proportion of patients with AUD 
only (10.9 %) reported abstinence compared to comorbid patients (30.9 
%) among those who received EUC only. One possible explanation for 
this observation is that comorbid patients were more aware that they 
had a health problem than patients with AUD only, resulting in a greater 
readiness to change. This has also been found in a previous investigation 
in a general practice high-income setting (Grothues et al., 2005) and is 
partly supported by the data, which indicate that more comorbid pa-
tients were “already trying to change” their drinking habits at baseline 
compared to non-comorbid patients. This may have made them more 
motivated to accomplish abstinence prior to assessment, while other 
potentially harmful drinking patterns (as measured via the AUDIT) may 
nonetheless have remained partly unchanged. 
We also conducted an additional exploratory analysis to investigate 
whether the effect of CAP in the group of comorbid patients is modified 
by the severity of depression, with results indicating that CAP may be 
effective in patients with mild comorbid depression, but may have no 
effect in patients with more severe depression (see appendix). This re-
quires further testing in larger studies as well as an improved qualitative 
understanding as to why this may be the case, ultimately informing 
guidelines on which disorder should be treated first in patients with 
comorbid AUD and depression. Interestingly, the stratified analysis also 
reveals a pattern similar to the one mentioned above: patients with less 
severe (i.e. mild) symptoms of depression seem to have responded 
consistently worse to EUC than those with at least moderate depression. 
With no difference in baseline intention to change between the two 
groups, this is a curious observation. Given that more severe symptoms 
of depression likely reflect dysfunctional thought patterns reducing a 
patient’s ability to improve their consumption habits (Hasin et al., 
2002), one might expect more severe symptoms of depression to be 
associated with a worse response to EUC only. This observation may well 
be entirely due to chance; however, it may be worth investigating 
further in future investigations. 
Looking at depression as the second outcome, study data suggest that 
the CAP intervention did not significantly improve depressive symptoms 
in comorbid participants compared to those who received EUC only. 
This finding is – once again – subject to the small sample size, but casts 
some doubt on the question of whether a treatment specifically tailored 
to addressing AUD may also be effective in the treatment of depression. 
Future research should consider developing and testing interventions 
which cater specifically to the needs of comorbid patients, thus 
addressing both disorders similarly and accounting for their possible 
interrelation. 
Data from this RCT also give insight into the prevalence of comorbid 
AUD and depression in a primary care setting – a question mostly un-
explored in India. The overall prevalence of comorbid AUD and 
depression was 2.8 % in this study population – however, this is sensitive 
to the PHQ-9 cut-off used to identify comorbid depression. In case of a 
higher cut-off (PHQ-9 ≥15) to identify at least moderately severe 
depression, this number goes down to 0.4 % - an estimate similar to 
community-level data from the NMHS (Gururaj et al., 2016), which used 
a different assessment tool (the Mini International Neuropsychiatric 
Interview). From a practical standpoint, this makes recruitment of co-
morbid patients in the given setting challenging. Researchers working in 
this field should explore different settings such as de-addiction centres, 
where a higher prevalence of comorbidity can be expected (Vohra et al., 
2003). Furthermore, baseline data of this trial support the hypothesis of 
a co-occurrence of AUD and depression: Among those who screened 
positive for AUD, 47.6 % also screened positive for at least mild co-
morbid depression and 7.1 % for at least moderately severe depression. 
Compared to prevalence data for at least moderately severe depression 
in the same setting (2.7 % overall (Patel et al., 2017)) and India-wide in 
the NMHS (2.37 % in men (Gururaj et al., 2016)), this is substantially 
higher and can be considered further evidence that the two disorders 
co-occur also in a LMIC-setting. As already noted, we also find that 
suffering from both AUD and depression is associated with significantly 
higher AUDIT scores, which should be considered further evidence that 
the experience of comorbidity is qualitatively different from just the sum 
of two disorders. 
This study has several important limitations: First, it was not pow-
ered to detect an intervention effect. Second, findings from this trial 
apply to men only, as women were not screened for AUD in the PRE-
MIUM trial. However, given the very low prevalence of AUD in Indian 
women (Gururaj et al., 2016), it seems unlikely that many have co-
morbid AUD and depression. Third, we relied on self-reported data for 
measuring alcohol consumption. Even though the AUDIT tool has been 
validated in the India context (Pal et al., 2004), we cannot rule out that 
alcohol intake has been reported differentially depending on treatment 
group. Fourth, we did not assess the presence of further comorbidities 
such as anxiety. If comorbid patients are more likely to suffer from e.g. 
anxiety, this may have impacted their response to CAP. Finally, we did 
not assess whether participants received additional treatment for either 
AUD or depression. However, given that most cases of depression and 
AUD remain unidentified and untreated in primary care in India 
(Gururaj et al., 2016), this is unlikely to have had a strong effect. 
5. Conclusions 
In conclusion, this study may be considered an encouraging starting 
point for systematically developing NSHW-delivered psychological 
treatments for the underserved and vulnerable population of comorbid 
patients with AUD and depression in India. Even though data from this 
study only allow for tentative claims about and partly cast doubt on the 
effectiveness of the AUD-only focused treatment tested here, they show 
that it can be safely delivered in a population of comorbid patients in an 
LMIC primary care setting. Hence, with accumulating knowledge 
through larger trials in settings with higher prevalence of comorbidity 
and more specifically tailored interventions to meet the needs of co-
morbid patients, brief psychological treatments delivered by NSHWs 
could become an important cornerstone in addressing the treatment gap 
for patients with comorbid depression and AUD in India. 
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